| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Interferon alfacon-1 |
Is a |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-n3 (substance) |
Is a |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-n1 lymphoblastoid |
Is a |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing interferon gamma-1b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing interferon beta-1a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1b-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing interferon alfa-2a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing interferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing peginterferon alfa-2b (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing interferon beta (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon gamma-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons allergy |
Causative agent (attribute) |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human interferon gamma-1b allergy |
Causative agent (attribute) |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to interferon alfa-2a |
Causative agent (attribute) |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to interferon alfa-2b (finding) |
Causative agent (attribute) |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to interferon alfa-n1 |
Causative agent (attribute) |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Human interferon gamma-1b 100micrograms/0.5mL injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 10million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 5million iu powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 3million iu injection (pdr for recon)+diluent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 1million iu injection (pdr for recon)+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 6million iu/mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 18million iu/1mL injection solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1b 8million iu injection (pdr for recon)+diluent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 1million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 4.5million iu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 5million units injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 10million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 30million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 3million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 9million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 18million iu injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 3million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons 10million iu/1mL solution for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferons (2) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 6million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 4.5million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 12million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 9million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1a 6million iu injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 15million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 25million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 50million iu/1mL prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 25million iu/2.5mL injection solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1a 12million iu/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1a 12million iu/0.5mL prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 18million iu/0.6mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2b 50micrograms injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2b 80micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2b 100micrograms powder and solvent for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2b 150micrograms injection (pdr for recon)+solvent (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2b 120micrograms injection (pdr for recon)+solvent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-n1-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 30000000iu solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 60million/iu solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 150mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 300mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 120mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 600mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 100.000mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 50mcg powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-n3 human leu 5000000unt/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 18000000iu/3mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 36000000iu/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 3miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 6miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 9miu injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfacon-130mcg/mL injection solution 0.3mL cartridge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1b 100mcg/ solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1a 30mcg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 5000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 25000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 50000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 10000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 3000000unt/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 18,000,000iu/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 25 millioniu/vial solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 18 millioniu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 10 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 3 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 5 million iu/vial solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Injectable interferon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2a-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-n3 human leu 5000000unt/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 6miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 9miu/vial injection solution 0.9mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 36000000iu/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 3miu/vial injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 18000000iu/3mL injection solution 3mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 3miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon beta-1a 30mcg/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2a 6miu/vial injection solution 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| PEG-intron redipen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| PEG-intron redipen 150micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| PEG-intron redipen 120micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| PEG-intron redipen 50micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| PEG-intron redipen 80micrograms powder+sterile water 0.5mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Interferon alfa-2b 10million iu/2mL injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2b 150micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Peginterferon alfa-2b 50micrograms powder+solvent for solution for injection in prefilled pen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Injectable interferon |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]